Viewing Study NCT00014495


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2025-12-28 @ 8:59 AM
Study NCT ID: NCT00014495
Status: COMPLETED
Last Update Posted: 2016-01-22
First Post: 2001-04-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent childhood acute myeloid leukemia View
None recurrent adult acute myeloid leukemia View
None accelerated phase chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None untreated adult acute myeloid leukemia View
None untreated childhood acute myeloid leukemia and other myeloid malignancies View
None refractory anemia with excess blasts View
None refractory anemia with excess blasts in transformation View
None chronic myelomonocytic leukemia View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None childhood chronic myelogenous leukemia View
None atypical chronic myeloid leukemia, BCR-ABL1 negative View
None myelodysplastic/myeloproliferative neoplasm, unclassifiable View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None childhood myelodysplastic syndromes View